# Genprex (GNPX) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/GNPX
## Company Profile
- Ticker: GNPX
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
- Tags: Gene Therapy, Oncology, Cardio-Metabolic
## Stock Data
- Close: 3.425 USD
- Market cap: 7783122.750399999 USD
- Last updated: 2026-09-03
## Business Overview
Genprex is a gene-therapy and oncology company focused on cancer and diabetes-related programs. Its platform has long centered on genetic medicine in difficult disease settings.
## Why The Stock Is Moving

As of Sep 3, 2026, GNPX closed down 2.42% at $3.42. No new same-company headline was identified in the current news window.

## Geographic Base

Headquartered in the United States and listed on NASDAQ, Genprex sits in specialty biotechnology.

## Business Model

The company depends on platform validation, clinical progress, and the ability to translate gene-delivery science into value.

## Landscape Position

Genprex is a high-catalyst genetic-medicine name with strong dependence on early results.

## Future Catalysts

- Genprex’s catalysts are the oncology and diabetes platforms, plus any strategic update that shows the company can still create value. The market needs a more convincing clinical path.

## Recent News
- 2023-09-21 12:30 EST — [Genprex Inc. (NASDAQ: GNPX) Receives Orphan Drug Designation for Immunogene Therapy for Treatment of SCLC](https://biopharmsignal.com/news/GNPX/genprex-inc-nasdaq-gnpx-receives-orphan-drug-designation-for-immunogene-therapy--a90e742e) — Source: Genprex
- 2019-09-06 12:30 EST — [Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Lung Cancer and Gene Therapy Treatments](https://biopharmsignal.com/news/GNPX/genprex-gnpx-featured-in-networknewsaudio-publication-discussing-lung-cancer-and-1468c4fe) — Source: Genprex
- 2019-09-05 12:30 EST — [Genprex (GNPX) Featured in NetworkNewsWire Publication Summarizing Gene Therapy Treatment for Lung Cancer](https://biopharmsignal.com/news/GNPX/genprex-gnpx-featured-in-networknewswire-publication-summarizing-gene-therapy-tr-f58cbc1d) — Source: Genprex
- 2019-08-23 12:30 EST — [Genprex (GNPX) Featured in Broadcast Discussing Strength, Potential of Biotech Sector](https://biopharmsignal.com/news/GNPX/genprex-gnpx-featured-in-broadcast-discussing-strength-potential-of-biotech-sect-57fe5510) — Source: Genprex
- 2019-08-22 12:30 EST — [Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Company’s Milestone Achievements](https://biopharmsignal.com/news/GNPX/genprex-gnpx-featured-in-networknewswire-publication-discussing-company-s-milest-b859845c) — Source: Genprex